Table: Towa Pharmaceutical -2018/19 group results

TOWA PHARMACEUTICAL

14/05/2019 07:00

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            105.10           93.43         111.00        58.00    
                 (+12.5 pct)     (+10.0 pct)    (+5.6 pct)   (+18.0 pct) 
  Operating         15.97           11.64          14.50         8.50    
                 (+37.1 pct)     (+69.5 pct)    (-9.2 pct)   (+43.5 pct) 
  Recurring         18.87           11.72          14.60         8.70    
                 (+61.0 pct)     (+58.0 pct)    (-22.6 pct)   (+3.9 pct) 
  Net
  Net               13.48            6.50          10.40         6.00    
                (+107.5 pct)     (+16.5 pct)    (-22.8 pct)   (-2.9 pct) 
  EPS            273.85 yen      132.00 yen     211.34 yen    121.93 yen 
  EPS Diluted    253.32 yen      122.03 yen                              
  Ann Div        107.50 yen       95.00 yen      44.00 yen               
  -Q2 Div         47.50 yen       47.50 yen      22.00 yen               
  -Q4 Div         60.00 yen       47.50 yen      22.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T